últimos artículos
En la Iniciativa Americana del Cribado del Cáncer de Pulmón nuestra misión es difundir la concientización sobre la importancia del cribado del cáncer de pulmón en personas de alto riesgo. Obtenga más información aquí sobre el cáncer de pulmón y las pruebas del cribado del cáncer de pulmón.
Key Articles
Below are key research articles relevant to lung cancer screening
Screening for Lung Cancer US Preventive Services Task Force Recommendation Statement
By: US Preventive Services Task Force
Where: JAMA. 2021;325(10):962-970. doi:10.1001/jama.2021.1117
New USPSTF Guidelines for Lung Cancer Screening
By: Yolonda L. Colson, MD, PhD; Jo-Anne O. Shepard, MD; Inga T. Lennes, MD, MPH, MBA
Broadened Eligibility for Lung Cancer Screening
By: Louise M. Henderson, PhD; M. Patricia Rivera, MD; Ethan Basch, MD
Expanded Access to Lung Cancer Screening- Implementing Wisely to Optimize Health
By: Anne C. Melzer, MD, MS; Timothy J. Wilt, MD, MPH
The Effect of Advances in Lung-Cancer Treatment on Population Mortality
By: Nadia Howlader, Gonçalo Forjaz, Meghan J. Mooradian, Rafael Meza, Chung Yin Kong, Kathleen A. Cronin, Angela B. Mariotto, Douglas R. Lowy, and Eric J. Feuer.
Where: NEJM, August 2020
Utilization of Lung Cancer Screening in the Medicare Fee-for-Service Population
By: Tina D. Tailor, Betty C. Tong, M.S2Junheng Gao, Louise M.Henderson, Kingshuk Roy, Choudhury Geoffrey D. Rubin
Where: Chest June 2020.
Results of Lung Cancer Screening in the Community
By: John R. Handy, Michael Skokan, Erika Rauch, Steven Zinck, Rachel E. Sanborn, Svetlana Kotova, and Mansen Wang
Where: The Annals of Family Medicine May 2020, 18 (3) 243-249
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial
By: Harry J. de Koning, M.D., Ph.D., Carlijn M. van der Aalst, Ph.D., Pim A. de Jong, M.D., Ph.D., Ernst T. Scholten, M.D., Ph.D., et al.
Where: New England Journal of Medicine February 2020, 382:503-513
By: Yung-Hung Luo, Lei Luo, Jason A Wampfler, Yi Wang, Dan Liu, Yuh-Min Chen, Alex A Adjei, David E Midthun, Ping Yang
Where: The Lancet Oncology, August 2019
By: U. Pastorino, M. Silva, S. Sestini, F. Sabia, M. Boeri, A. Cantarutti, N. Sverzellati, G. Sozzi, G. Corrao, A. Marchianò
Where: Annals of Oncology, July 2019
Evaluation of USPSTF Lung Cancer Screening Guidelines Among African American Adult Smokers
By: Melinda C. Aldrich, Sarah F. Mercaldo, Kim L. Sandler, William J. Blot, Eric L. Grogan, Jeffrey D. Blume
Where: JAMA Oncology, June 2019
By: Douglas E. Wood
Where: CHEST, June 2018
Selecting Lung Cancer Screenees Using Risk Prediction Models - where do we go from here
By: Martin C Tammemägi
Where: Translational Lung Cancer Research June 2018; 7(3) 243-253
Evaluating efficacy of current lung cancer screening guidelines
By: Barbara Nemesure, April Plank, Lisa Reagan, Denise Albano, Michael Reiter, Thomas V Bilfinger
Where: J Med Screen, Dec 2017
Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment
By: Paul F Pinsky, David S Gierada, William Black, Reginald Munden, Hrudaya Nath, Denise Aberle, Ella Kazerooni
Where: Ann Intern Med., April 2015
Experience with a CT screening program for individuals at high risk for developing lung cancer
By: Brady J McKee, Jeffrey A Hashim, Robert J French, Andrea B McKee, Paul J Hesketh, Carla R Lamb, Christina Williamson, Sebastian Flacke, Christoph Wald
Where: J Am Coll Radiol., February 2015
By: Raja Flores, Thomas Bauer, Ralph Aye, Shahriyour Andaz, Leslie Kohman, Barry Sheppard, William Mayfield, Richard Thurer, Michael Smith, Robert Korst, Michaela Straznicka, Fred Grannis, Harvey Pass, Cliff Connery, Rowena Yip, James P Smith, David Yankelevitz, Claudia Henschke, Nasser Altorki, I-ELCAP Investigators
Where: J Thorac Cardiovasc Surg, May 2014
Clinical characteristics and survival in never smokers with lung cancer
By: Isaura Parente Lamelas , José Abal Arca , Nagore Blanco Cid , María Teresa Alves Pérez, Raquel Dacal Quintas, Hugo Gómez Márquez, Rogelio Alejandro García Montenegro, Pedro Marcos Velázquez
Where: Arch Bronconeumologia, February 2014
Annual number of lung cancer deaths potentially avertable by screening in the United States
By: Jiemin Ma, Elizabeth M Ward, Robert Smith, Ahmedin Jemal
Where: Cancer, April 2013
By: Darren R. Brenner, Paolo Boffetta, Eric J. Duell, Heike Bickeböller, Albert Rosenberger, Valerie McCormack, Joshua E. Muscat, Ping Yang, H.-Erich Wichmann, Irene Brueske-Hohlfeld, Ann G. Schwartz, Michele L. Cote, Anne Tjønneland, Søren Friis, Loic Le Marchand, Zuo-Feng Zhang, Hal Morgenstern, Neonila Szeszenia-Dabrowska, Jolanta Lissowska, David Zaridze, Peter Rudnai, Eleonora Fabianova, Lenka Foretova, Vladimir Janout, Vladimir Bencko, Miriam Schejbalova, Paul Brennan, Ioan N. Mates, Philip Lazarus, John K. Field, Olaide Raji, John R. McLaughlin, Geoffrey Liu, John Wiencke, Monica Neri, Donatella Ugolini, Angeline S. Andrew, Qing Lan, Wei Hu, Irene Orlow, Bernard J. Park, and Rayjean J. Hung
Where: American Journal of Epidemiology, October 2012
By: Paul F Pinsky, Christine D Berg
Where: J Med Screen, September 2012
By: Douglas E. Wood, George A. Eapen, David S. Ettinger, Lifang Hou, David Jackman, Ella Kazerooni, Donald Klippenstein, Rudy P. Lackner, Lorriana Leard, Ann N. C. Leung, Pierre P. Massion, Bryan F. Meyers, Reginald F. Munden, Gregory A. Otterson, Kimberly Peairs, Sudhakar Pipavath, Christie Pratt-Pozo, Chakravarthy Reddy, Mary E. Reid, Arnold J. Rotter, Matthew B. Schabath, Lecia V. Sequist, Betty C. Tong, William D. Travis, Michael Unger, and Stephen C. Yang
Where: JNCCN, February 2012
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
By: The National Lung Screening Trial Research Team
Where: NEJM, August 2011